These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 10583

  • 1. Treatment of depression with tricyclic drugs--pharmacokinetic and pharmacodynamic aspects.
    Asberg M.
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jan; 9(1):18-26. PubMed ID: 10583
    [Abstract] [Full Text] [Related]

  • 2. Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine.
    Asberg M, Ringberger VA, Sjöqvist F, Thorén P, Träskman L, Tuck JR.
    Clin Pharmacol Ther; 1977 Feb; 21(2):201-7. PubMed ID: 13959
    [Abstract] [Full Text] [Related]

  • 3. Plasma levels of tricyclic antidepressants and clinical efficacy: review of the literature -- part II.
    Risch SC, Huey LY, Janowsky DS.
    J Clin Psychiatry; 1979 Feb; 40(2):58-69. PubMed ID: 581671
    [Abstract] [Full Text] [Related]

  • 4. [Use of antidepressants: pharmacokinetic basis (author's transl)].
    Cronholm B.
    Encephale; 1979 Feb; 5(5 Suppl):605-15. PubMed ID: 95008
    [Abstract] [Full Text] [Related]

  • 5. Relationship of CSF neurotransmitter metabolite levels to disease severity and disability in multiple sclerosis.
    Markianos M, Koutsis G, Evangelopoulos ME, Mandellos D, Karahalios G, Sfagos C.
    J Neurochem; 2009 Jan; 108(1):158-64. PubMed ID: 19014375
    [Abstract] [Full Text] [Related]

  • 6. Hydroxylated metabolites of tricyclic antidepressants: preclinical assessment of activity.
    Potter WZ, Calil HM, Manian AA, Zavadil AP, Goodwin FK.
    Biol Psychiatry; 1979 Aug; 14(4):601-13. PubMed ID: 486616
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic effects of serotonin uptake inhibitors in depression.
    Asberg M, Eriksson B, Mårtensson B, Träskman-Bendz L, Wägner A.
    J Clin Psychiatry; 1986 Apr; 47 Suppl():23-35. PubMed ID: 2937776
    [Abstract] [Full Text] [Related]

  • 8. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M.
    Med Biol; 1985 Apr; 63(1):1-17. PubMed ID: 2582215
    [Abstract] [Full Text] [Related]

  • 9. Differential effect of chlorimipramine and nortriptyline on cerebrospinal fluid metabolites of serotonin and noradrenaline in depression.
    Bertilsson L, Asberg M, Thorén P.
    Eur J Clin Pharmacol; 1974 Aug 23; 7(5):365-8. PubMed ID: 4420178
    [No Abstract] [Full Text] [Related]

  • 10. Concentrations of monoamine metabolites and chlorpromazine in cerebrospinal fluid for prediction of therapeutic response in psychotic patients treated with neuroleptic drugs.
    Sedvall G.
    Prog Biochem Pharmacol; 1980 Aug 23; 16():133-40. PubMed ID: 6160594
    [Abstract] [Full Text] [Related]

  • 11. The Harold E. Himwich Memorial Lecture. Significance of biochemical parameters in the diagnosis, treatment, and prevention of depressive disorders.
    Praag HM.
    Biol Psychiatry; 1977 Feb 23; 12(1):101-31. PubMed ID: 300032
    [Abstract] [Full Text] [Related]

  • 12. The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: a meta-analysis.
    Lester D.
    Pharmacopsychiatry; 1995 Mar 23; 28(2):45-50. PubMed ID: 7542785
    [Abstract] [Full Text] [Related]

  • 13. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
    Carpenter LL, Moreno FA, Kling MA, Anderson GM, Regenold WT, Labiner DM, Price LH.
    Biol Psychiatry; 2004 Sep 15; 56(6):418-26. PubMed ID: 15364040
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder.
    Sher L, Carballo JJ, Grunebaum MF, Burke AK, Zalsman G, Huang YY, Mann JJ, Oquendo MA.
    Bipolar Disord; 2006 Oct 15; 8(5 Pt 2):543-50. PubMed ID: 17042827
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Biochemical effects of antidepressant treatment--studies of monoamine metabolites in cerebrospinal fluid and platelet [3H]imipramine binding.
    Asberg M, Wägner A.
    Ciba Found Symp; 1986 Oct 15; 123():57-83. PubMed ID: 2434288
    [Abstract] [Full Text] [Related]

  • 18. Studies of amine metabolites in affective illness and in schizophrenia: a comparative analysis.
    Goodwin FK, Post RM.
    Res Publ Assoc Res Nerv Ment Dis; 1975 Oct 15; 54():299-332. PubMed ID: 769117
    [No Abstract] [Full Text] [Related]

  • 19. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE, Foxx JL, Butler IJ.
    Ann Neurol; 1980 Jul 15; 8(1):38-42. PubMed ID: 6157351
    [Abstract] [Full Text] [Related]

  • 20. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
    Ballon N, Siobud-Dorocant E, Even C, Slama F, Dardennes R.
    Encephale; 2001 Jul 15; 27(4):373-6. PubMed ID: 11686060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.